safety by nature depictionsafety by nature depiction
Corporate Social Responsibility
 

Corporate Sponsorship

Intralytix proudly supports the advancement of phage-based science and applications through corporate sponsorships and collaborations.

Supported Conferences

Viruses of Microbes (VoM) 2026, Prague, Check Republic
1st International Symposium on Advances in Phage Therapeutics, Braga, Portugal, 2025
Viruses of Microbes (VoM) 2024, Cairns, Australia
American Society for Microbiology (ASM), Bacteriophage Division 2024
American Society for Microbiology (ASM), Bacteriophage Division 2023
Viruses of Microbes (VoM) 2023, Tbilisi, Georgia
10th Microbiome R&D & Business Collaboration Forum USA, 2022
9th Microbiome R&D and Business Collaboration Forum USA, 2022
5th Probiotics congress USA, 2022
3rd Skin Microbiome and Cosmeceuticals Congress USA, 2022
10th Microbiome R&D and Business Collaboration Forum: Europe, 2022
7th Probiotics & Prebiotics Congress: Europe, 2022
4th Skin Microbiome & Cosmeceuticals Congress: Europe, 2022
Viruses of Microbes (VoM), 2022, Guimarães, Portugal
Evergreen Phage Conference, 2019
American Society for Microbiology (Bacteriophage Division), 2019
Centennial Celebration of Bacteriophage Research, Institute Pasteur, 2017

Intralytix also supports small phage-related R&D projects in the U.S. and internationally (e.g., France, Russia, Denmark, Philippines).

For inquiries on sponsorships or phage R&D project opportunities, contact us at: info@intralytix.com

*Funding levels depend on extent of project with indirect cost rates strictly limited to a maximum of 30%.

Back to Corporate
"Investing in the next generation of bacteriophage research and scientific collaboration."